Atlas Trials

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

Clinical trial NCT02116361 · COMPLETED

Trial details

NCT number
NCT02116361
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2014-04-22
Primary completion
2016-08-25
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.